Literature DB >> 29415598

Mantle Cell Lymphoma with t(11;22) (q13;q11.2) an indolent clinical variant?

William D Marrero1, Alexis Cruz-Chacón1, Fernando Cabanillas1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29415598     DOI： 10.1080/10428194.2018.1427863

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

Review 1.  Molecular Pathogenesis of Mantle Cell Lymphoma.

Authors:  Alba Navarro; Sílvia Beà; Pedro Jares; Elías Campo
Journal:  Hematol Oncol Clin North Am       Date:  2020-07-22       Impact factor: 3.722

2.  Truncation of 3' CCND1 by t(11;22) leads to negative SP4 CCND1 immunohistochemistry in blastoid mantle cell lymphoma.

Authors:  Fumiyo Maekawa; Chiyuki Kishimori; Miho Nakagawa; Kayo Takeoka; Katsuhiro Fukutsuka; Masahiko Hayashida; Futoshi Iioka; Masakazu Fujimoto; Kengo Takeuchi; Hirokazu Nakamine; Hitoshi Ohno
Journal:  Blood Adv       Date:  2021-01-12

Review 3.  Current Knowledge in Genetics, Molecular Diagnostic Tools, and Treatments for Mantle Cell Lymphomas.

Authors:  Shenon Sethi; Zachary Epstein-Peterson; Anita Kumar; Caleb Ho
Journal:  Front Oncol       Date:  2021-11-23       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.